SubjectVerb relationObjectSentenceSentimentTitleUrlDate
Abbvie Inc said on Thursday it settled all patent disputes with Novartis AG granting it nonexclusive license to manufacture and sell copycat version of blockbuster drug Humira Abbvie Inc said on Thursday it settled all patent disputes with Novartis AG granting it a nonexclusive license to manufacture and sell a copycat version of blockbuster drug Humira NegativeAbbvie Inc said on Thursday it settled all patent disputes with Novartis AG granting it a nonexclusive license to manufacture and sell a copycat version of blockbuster drug Humira http://www.reuters.com/finance/article/us-abbvie-novartis-humira/abbvie-settles-humira-patent-disputes-with-novartis-unit-idUSKCN1ML31B2018-10-12
Sandoz received marketing approval for its Humira biosimilar from European Commission in July and had submitted its application to U.S. health regulator early this year Sandoz received marketing approval for its Humira biosimilar from the European Commission in July and had submitted its application to the U.S. health regulator early this year NegativeAbbvie Inc said on Thursday it settled all patent disputes with Novartis AG granting it a nonexclusive license to manufacture and sell a copycat version of blockbuster drug Humira http://www.reuters.com/finance/article/us-abbvie-novartis-humira/abbvie-settles-humira-patent-disputes-with-novartis-unit-idUSKCN1ML31B2018-10-12
Humira is worlds bestselling prescription medicine and has long buoyed AbbVies business raking in Humira is the worlds bestselling prescription medicine and has long buoyed AbbVies business raking in NegativeAbbvie Inc said on Thursday it settled all patent disputes with Novartis AG granting it a nonexclusive license to manufacture and sell a copycat version of blockbuster drug Humira http://www.reuters.com/finance/article/us-abbvie-novartis-humira/abbvie-settles-humira-patent-disputes-with-novartis-unit-idUSKCN1ML31B2018-10-12